The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
Guangjian Li, Xu Wang, Dihui Ma Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, People’s Republic of China Background: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy and...
Enregistré dans:
Auteurs principaux: | Li G, Wang X, Ma D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1db9583fa120422ab8c7f7e5b2bbf9fe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
par: McIntyre RS, et autres
Publié: (2021) -
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
par: Fu J, et autres
Publié: (2016) -
Cognitive impairment in depression: recent advances and novel treatments
par: Perini G, et autres
Publié: (2019) -
Pioglitazone could induce remission in major depression: a meta-analysis
par: Colle R, et autres
Publié: (2016) -
Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
par: Huang Q, et autres
Publié: (2016)